Skip to main content
SABS logo

SABS · SAB Biotherapeutics, Inc. · Holdings

Track SABS — free
$2.91 -0.07 (-2.35%)
Market Cap
$271.14M
Shares
90.99M
Volume · Oct 12 102.58K Avg daily vol (3M) 500.25K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Some SEC filings for this period have not finished importing. Holder totals and changes may be incomplete; these filings remain queued for recovery.
The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 94
Total Value: $268,271,526
Total Shares: 69,687,825
Showing 1–100 of 101 holdings by value · page 1 of 2

Institutional Ownership Trend

23 quarters

Holder Concentration

Across 93 13F filers
Top Holder
11.6%
Sep 2023 → Jun 2026 · range 11.6% – 47.7%
of institutional value
Top 5
47.5%
Sep 2023 → Jun 2026 · range 47.5% – 93.3%
of institutional value
Top 10
70.0%
Sep 2023 → Jun 2026 · range 70.0% – 99.0%
of institutional value
HHI
618
Sep 2023 → Jun 2026 · range 618 – 3,090
Broadly held
Showing 100 of 101
Export CSV
Holder Value (USD) % of 13F Shares Open

Showing the top 100 of 101 holders. Create a free account to see every holder, past quarters, search, filters and CSV export.

Key facts CIK 1833214 CUSIP 78397T202 13F (30d) 2 filings 2 filers Visit website Investor relations